124 related articles for article (PubMed ID: 30421058)
1. Adjuvant Therapy is Associated with Improved Survival in pT1N1 Gastric Cancer in a Heterogeneous Western Patient Population.
Hester CA; Augustine MM; Mansour JC; Polanco PM; Yopp AC; Zeh HJ; Wang SC; Porembka MR
Ann Surg Oncol; 2019 Jan; 26(1):167-176. PubMed ID: 30421058
[TBL] [Abstract][Full Text] [Related]
2. The addition of chemoradiation to adjuvant chemotherapy is associated with improved survival in lymph node-positive gastric cancer.
Altman AM; Sheka AC; Marmor S; Lou E; Reynolds M; Hui JYC; Tuttle TM; Jensen EH; Denbo JW
Surg Oncol; 2020 Sep; 34():134-139. PubMed ID: 32891318
[TBL] [Abstract][Full Text] [Related]
3. Implications of Lymph Node Staging on Selection of Adjuvant Therapy for Gastric Cancer in the United States: A Propensity Score-matched Analysis.
Datta J; McMillan MT; Ecker BL; Karakousis GC; Mamtani R; Plastaras JP; Giantonio BJ; Drebin JA; Dempsey DT; Fraker DL; Roses RE
Ann Surg; 2016 Feb; 263(2):298-305. PubMed ID: 26135687
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant Therapy Improves Survival for T2N0 Gastric Cancer Patients with Sub-optimal Lymphadenectomy.
In H; Kantor O; Sharpe SM; Baker MS; Talamonti MS; Posner MC
Ann Surg Oncol; 2016 Jun; 23(6):1956-62. PubMed ID: 26753752
[TBL] [Abstract][Full Text] [Related]
5. Impact of external-beam radiation therapy on outcomes among patients with resected gastric cancer: a multi-institutional analysis.
Ejaz A; Spolverato G; Kim Y; Squires MH; Poultsides G; Fields R; Bloomston M; Weber SM; Votanopoulos K; Worhunsky DJ; Swords D; Jin LX; Schmidt C; Acher AW; Saunders N; Cho CS; Herman JM; Maithel SK; Pawlik TM
Ann Surg Oncol; 2014 Oct; 21(11):3412-21. PubMed ID: 24845728
[TBL] [Abstract][Full Text] [Related]
6. Comparative effectiveness of treatment modalities in non-metastatic gastric adenocarcinoma: a propensity score matching analysis of the National Cancer Database.
Barzi A; Yang D; Kim AW; Shah MA; Sadeghi S
BMJ Open Gastroenterol; 2020 Nov; 7(1):. PubMed ID: 33148789
[TBL] [Abstract][Full Text] [Related]
7. Impact of lymph node ratio in selecting patients with resected gastric cancer for adjuvant therapy.
Kim Y; Squires MH; Poultsides GA; Fields RC; Weber SM; Votanopoulos KI; Kooby DA; Worhunsky DJ; Jin LX; Hawkins WG; Acher AW; Cho CS; Saunders N; Levine EA; Schmidt CR; Maithel SK; Pawlik TM
Surgery; 2017 Aug; 162(2):285-294. PubMed ID: 28578142
[TBL] [Abstract][Full Text] [Related]
8. Addition of radiotherapy to adjuvant chemotherapy is associated with improved overall survival in resected pancreatic adenocarcinoma: An analysis of the National Cancer Data Base.
Rutter CE; Park HS; Corso CD; Lester-Coll NH; Mancini BR; Yeboa DN; Johung KL
Cancer; 2015 Dec; 121(23):4141-9. PubMed ID: 26280559
[TBL] [Abstract][Full Text] [Related]
9. The ypT category does not impact overall survival in node negative gastric cancer.
Ikoma N; Hofstetter WL; Estrella JS; Das P; Minsky BD; Fournier KF; Mansfield PF; Ajani JA; Badgwell BD
J Surg Oncol; 2018 Jun; 117(8):1721-1728. PubMed ID: 29949666
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant Chemotherapy Versus Chemoradiotherapy Versus Surgery Alone for Early Gastric Cancer with One or Two Lymph Node Metastasis.
Kim SM; An JY; Lee J; Sohn TS; Kim S
Ann Surg Oncol; 2018 Jun; 25(6):1616-1624. PubMed ID: 29569127
[TBL] [Abstract][Full Text] [Related]
11. Lymph Node Burden as a Predictive Factor for Selective Chemoradiotherapy in Patients With Locally Advanced Gastric Cancer After a D2 Dissection: A Retrospective Study.
Li Q; Li G; Palmer JD; Zhang Z
Am J Clin Oncol; 2017 Aug; 40(4):375-380. PubMed ID: 25503428
[TBL] [Abstract][Full Text] [Related]
12. Revisiting a dogma: similar survival of patients with small bowel and gastric GIST. A population-based propensity score SEER analysis.
Guller U; Tarantino I; Cerny T; Ulrich A; Schmied BM; Warschkow R
Gastric Cancer; 2017 Jan; 20(1):49-60. PubMed ID: 26649434
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant chemotherapy versus chemoradiotherapy in the management of patients with surgically resected duodenal adenocarcinoma: A propensity score-matched analysis of a nationwide clinical oncology database.
Ecker BL; McMillan MT; Datta J; Lee MK; Karakousis GC; Vollmer CM; Drebin JA; Fraker DL; Roses RE
Cancer; 2017 May; 123(6):967-976. PubMed ID: 28263387
[TBL] [Abstract][Full Text] [Related]
14. Does chemoradiotherapy improve outcomes for surgically resected adenocarcinoma of the stomach or esophagus?
Solomon NL; Cheung MC; Byrne MM; Zhuge Y; Franceschi D; Livingstone AS; Koniaris LG
Ann Surg Oncol; 2010 Jan; 17(1):98-108. PubMed ID: 19777191
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant radiotherapy improves overall survival in patients with resected gastric adenocarcinoma: A National Cancer Data Base analysis.
Stumpf PK; Amini A; Jones BL; Koshy M; Sher DJ; Lieu CH; Schefter TE; Goodman KA; Rusthoven CG
Cancer; 2017 Sep; 123(17):3402-3409. PubMed ID: 28513823
[TBL] [Abstract][Full Text] [Related]
16. Prognostic analysis of patients with operable gastric cancer and tolerability to adjuvant radio-chemo-therapy.
Kucukoner M; Arpaci E; Isikdogan A; Bilici M; Uncu D; Cetin B; Dane F; Inanc M; Ekinci AS; Inal A; Cayir K; Yetisyigit T; Ozdemir N; Kaplan MA; Aksoy S; Alkıs N; Tekin SB; Eroglu C; Turhal S; Buyukberber S
Neoplasma; 2013; 60(1):19-25. PubMed ID: 23067212
[TBL] [Abstract][Full Text] [Related]
17. Multimodality Therapy Improves Survival in Resected Early Stage Gastric Cancer in the United States.
Datta J; McMillan MT; Ruffolo L; Lowenfeld L; Mamtani R; Plastaras JP; Dempsey DT; Karakousis GC; Drebin JA; Fraker DL; Roses RE
Ann Surg Oncol; 2016 Sep; 23(9):2936-45. PubMed ID: 27090793
[TBL] [Abstract][Full Text] [Related]
18. Evaluating the fate of patients who undergo resections of very large, node-negative lung cancers using the National Cancer DataBase.
Liu J; Hancock JG; Moreno AC; Wang Z; Boffa DJ; Detterbeck FC; Kim AW
Eur J Cardiothorac Surg; 2016 Feb; 49(2):596-601. PubMed ID: 25890936
[TBL] [Abstract][Full Text] [Related]
19. Predictors of Positive Margins After Definitive Resection for Gastric Adenocarcinoma and Impact of Adjuvant Therapies.
Rhome RM; Moshier E; Sarpel U; Ohri N; Mazumdar M; Buckstein MH
Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1106-1115. PubMed ID: 28721894
[TBL] [Abstract][Full Text] [Related]
20. Perioperative chemotherapy vs. neoadjuvant chemoradiation in gastroesophageal junction adenocarcinoma : A population-based evaluation of the Munich Cancer Registry.
Münch S; Habermehl D; Agha A; Belka C; Combs SE; Eckel R; Friess H; Gerbes A; Nüssler NC; Schepp W; Schmid RM; Schmitt W; Schubert-Fritschle G; Weber B; Werner J; Engel J
Strahlenther Onkol; 2018 Feb; 194(2):125-135. PubMed ID: 29071366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
